IS8277A - Blanda af serótónín endurupptöku hindra og glysínflutningsprótín gerð I hindra við meðferð á þunglyndi - Google Patents
Blanda af serótónín endurupptöku hindra og glysínflutningsprótín gerð I hindra við meðferð á þunglyndiInfo
- Publication number
- IS8277A IS8277A IS8277A IS8277A IS8277A IS 8277 A IS8277 A IS 8277A IS 8277 A IS8277 A IS 8277A IS 8277 A IS8277 A IS 8277A IS 8277 A IS8277 A IS 8277A
- Authority
- IS
- Iceland
- Prior art keywords
- inhibitor
- depression
- mixture
- treatment
- serotonin reuptake
- Prior art date
Links
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 title 2
- 102000014914 Carrier Proteins Human genes 0.000 title 1
- 108010078791 Carrier Proteins Proteins 0.000 title 1
- 208000020401 Depressive disease Diseases 0.000 title 1
- 239000004471 Glycine Substances 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 229940126570 serotonin reuptake inhibitor Drugs 0.000 title 1
- 239000003772 serotonin uptake inhibitor Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Diabetes (AREA)
- Hospice & Palliative Care (AREA)
- Child & Adolescent Psychology (AREA)
- Hematology (AREA)
- Pain & Pain Management (AREA)
- Addiction (AREA)
- Anesthesiology (AREA)
- Nutrition Science (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US49673803P | 2003-08-21 | 2003-08-21 | |
| DKPA200301198 | 2003-08-21 | ||
| PCT/DK2004/000547 WO2005018676A1 (en) | 2003-08-21 | 2004-08-18 | The combination of a serotonin reuptake inhibitor and a glycine transporter type 1 inhibitor for the treatment of depression |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IS8277A true IS8277A (is) | 2006-01-31 |
Family
ID=34219531
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IS8277A IS8277A (is) | 2003-08-21 | 2006-01-31 | Blanda af serótónín endurupptöku hindra og glysínflutningsprótín gerð I hindra við meðferð á þunglyndi |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20060223857A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1660130A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2007502785A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20060066729A (cg-RX-API-DMAC7.html) |
| CN (1) | CN1867358A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2004266057A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BRPI0413587A (cg-RX-API-DMAC7.html) |
| CA (1) | CA2536275A1 (cg-RX-API-DMAC7.html) |
| IS (1) | IS8277A (cg-RX-API-DMAC7.html) |
| MX (1) | MXPA06002002A (cg-RX-API-DMAC7.html) |
| NO (1) | NO20061167L (cg-RX-API-DMAC7.html) |
| WO (1) | WO2005018676A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2005513128A (ja) * | 2001-12-20 | 2005-05-12 | ハー・ルンドベック・アクチエゼルスカベット | アリールオキシフェニル及びアリールスルファニルフェニル誘導体 |
| WO2008100727A2 (en) * | 2007-02-14 | 2008-08-21 | The Trustees Of Columbia University In The City Of New York | High-dose glycine as a treatment for obsessive-compulsive disorder and obsessive-compulsive spectrum disorders |
| CN101338337B (zh) * | 2007-07-04 | 2011-11-02 | 北京华安佛医药研究中心有限公司 | 多态性位点基因型预测抑郁症及药效的用途、方法和试剂盒 |
| EP2380595A1 (en) | 2010-04-19 | 2011-10-26 | Nlife Therapeutics S.L. | Compositions and methods for selective delivery of oligonucleotide molecules to specific neuron types |
| CN102949364A (zh) * | 2011-08-30 | 2013-03-06 | 天津药物研究院 | 一种含有效成分盐酸维拉佐酮的缓释片 |
| EP3870292A4 (en) | 2018-10-26 | 2022-11-09 | The Research Foundation for The State University of New York | COMBINATION OF SEROTONIN-SPECIFIC RESUPPUT INHIBITOR AND SEROTONIN 1A RECEPTOR PARTIAL AGONIST TO REDUCE L-DOPA-INDUCED DYSKINESIA |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6361957B1 (en) * | 1999-08-03 | 2002-03-26 | Glytech, Inc. | Assay for D-serine transport antagonist and use for treating psychosis |
| IL124536A (en) * | 1995-12-07 | 2001-03-19 | Daniel C Javitt | Pharmaceutical compositions containing a glycine uptake antagonist |
| AU730789B2 (en) * | 1996-05-31 | 2001-03-15 | Nps Pharmaceuticals, Inc. | Pharmaceutical for treatment of neurological and neuropsychiatric disorders |
| US6117855A (en) * | 1996-10-07 | 2000-09-12 | Merck Sharp & Dohme Ltd. | Use of a NK-1 receptor antagonist and an antidepressant and/or an anti-anxiety agent |
| GB2336534A (en) * | 1998-04-24 | 1999-10-27 | Alec James Coppen | Anti-depressant - Folic Acid Combination |
| DOP2001000189A (es) * | 2000-06-30 | 2002-03-30 | Pfizer Prod Inc | Benzofenonas y sulfonas como inhibidores de la captación de glicina |
| AU2001281740B2 (en) * | 2000-07-21 | 2006-02-16 | H. Lundbeck A/S | Novel compounds and their use as glycine transport inhibitors |
| JP2005513128A (ja) * | 2001-12-20 | 2005-05-12 | ハー・ルンドベック・アクチエゼルスカベット | アリールオキシフェニル及びアリールスルファニルフェニル誘導体 |
| KR20050012284A (ko) * | 2002-06-20 | 2005-01-31 | 하. 룬트벡 아크티에 셀스카브 | 세로토닌 재흡수 저해제가 사용되는 병용 치료법 |
| KR20070104480A (ko) * | 2003-05-27 | 2007-10-25 | 포레스트 래보러토리즈, 인코포레이티드 | 우울증 및 그 밖의 기분장애의 치료를 위한 ｎｍｄａ수용체 길항제 및 선택적 세로토닌 재흡수 억제제의 배합물 |
-
2004
- 2004-08-18 EP EP04739042A patent/EP1660130A1/en not_active Withdrawn
- 2004-08-18 CN CNA2004800304533A patent/CN1867358A/zh active Pending
- 2004-08-18 JP JP2006523530A patent/JP2007502785A/ja not_active Withdrawn
- 2004-08-18 AU AU2004266057A patent/AU2004266057A1/en not_active Abandoned
- 2004-08-18 WO PCT/DK2004/000547 patent/WO2005018676A1/en not_active Ceased
- 2004-08-18 CA CA002536275A patent/CA2536275A1/en not_active Abandoned
- 2004-08-18 US US10/568,133 patent/US20060223857A1/en not_active Abandoned
- 2004-08-18 KR KR1020067003210A patent/KR20060066729A/ko not_active Withdrawn
- 2004-08-18 MX MXPA06002002A patent/MXPA06002002A/es not_active Application Discontinuation
- 2004-08-18 BR BRPI0413587-3A patent/BRPI0413587A/pt not_active IP Right Cessation
-
2006
- 2006-01-31 IS IS8277A patent/IS8277A/is unknown
- 2006-03-13 NO NO20061167A patent/NO20061167L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2536275A1 (en) | 2005-03-03 |
| KR20060066729A (ko) | 2006-06-16 |
| NO20061167L (no) | 2006-03-13 |
| WO2005018676A1 (en) | 2005-03-03 |
| US20060223857A1 (en) | 2006-10-05 |
| JP2007502785A (ja) | 2007-02-15 |
| AU2004266057A1 (en) | 2005-03-03 |
| CN1867358A (zh) | 2006-11-22 |
| EP1660130A1 (en) | 2006-05-31 |
| BRPI0413587A (pt) | 2006-10-17 |
| MXPA06002002A (es) | 2006-05-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20043564L (no) | Follistatindomene som inneholder proteiner | |
| DK1495128T3 (da) | Forstærket proteinekspression i Bacillus | |
| EP1636250A4 (en) | SELF-ORGANIZING PEPTIDES CONTAINING MODIFICATIONS AND METHOD FOR THEIR USE | |
| DK1711207T3 (da) | Interferon-alpha-antistoffer og anvendelse heraf | |
| IL228034A0 (en) | Formulations with a high concentration of antibodies and proteins | |
| NO20055306D0 (no) | GITR ligand og GITR ligand relaterte molekyler og antistoffer og anvendelse derav | |
| EP1732581A4 (en) | POLYPEPTIDE TRANSDUCTION AND FUSOGENIC PEPTIDES | |
| DK1268431T3 (da) | 3-Cyanoquinoliner, 3-cyano-1,6-naphthyridiner og 3-cyano-1,7-naphthyridiner som proteinkinaseinhibitorer | |
| SI1641823T1 (sl) | Fuzijski proteini analogni glp-1 | |
| DK1661113T3 (da) | System og fremgangsmåde til fælles aflevering i realtid af talrige attributter | |
| DK1534277T3 (da) | Acylerede, heteroaryl-kondenserede cycloalkenylaminer og anvendelse af disse som lægemidler | |
| DK1663291T3 (da) | Rekombinante lubricinmolekyler og anvendelser deraf | |
| DE60336880D1 (de) | Vorrichtungen zur Dekodierung von bewegten Bildern | |
| DK3401327T3 (da) | Genprodukter med forskellig ekspression i tumorer og anvendelser deraf | |
| IS7858A (is) | Samsetning til notkunar í meðferð á athyglisbresti með ofvirkni (ADHD) | |
| IS8277A (is) | Blanda af serótónín endurupptöku hindra og glysínflutningsprótín gerð I hindra við meðferð á þunglyndi | |
| NO20055708D0 (no) | Syntetisk gen som koder for humant karsinembryonalt antigen og anvendelser derav | |
| IS8308A (is) | Amínósýrur með sækni fyrir a2o prótíninu | |
| IS8489A (is) | Umritunarstillar og aðferðir þeirra | |
| EP1734983A4 (en) | MODIFIED ANNEXINE PROTEINS AND METHODS FOR PREVENTING THROMBOSIS | |
| IS7962A (is) | Þíenópýridasínón og notkun þeirra í breytingu á sjálfsnæmissjúkdómi | |
| IS8326A (is) | Blandan af serótónín endurupptöku hindra og loxapíni | |
| FI20040655L (fi) | Proteiini- ja peptidistabilointi | |
| NO20055668D0 (no) | Beta-amyloidinhibitorer og anvendelse derav | |
| FI20030315A0 (fi) | Menetelmiä ja konstruktioita valikoitujen aminohappojen pitoisuuksien lisäämiseksi siemenissä |